Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P52742 (
pT3
)
1,034
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Cytotoxic T lymphocyte-associated antigen 4 (
CTLA-4
,
CD152
) and Foxp3 (forkhead box P3) are receptors present on T cells which play a critical role in the down-regulation of antigen-activated immune responses. To evaluate the potential influences of
CTLA-4
and Foxp3 on cancer invasiveness, a case-control study was conducted in 86 patients treated for squamous cell laryngeal carcinoma. The abundance of
CTLA-4
and Foxp3 gene transcripts in the purified peripheral blood mononuclear cells (PBMCs) by quantitative real-time PCR (qRT-PCR) was determined. The analysis of proteins by Western blot was performed. The relationships between
CTLA-4
and Foxp3 gene and protein expression as well as the aggressiveness of tumor determined on pT, type and depth of invasion were investigated. Our work revealed a significant dependence of mRNA
CTLA-4
on tumor front grading (TFG) total score (p = 0.04) as well as
CTLA-4
protein expression on pT (p = = 0.03) and type of invasion (p = 0.03). Advanced
pT3
-pT4 tumors with diffuse infiltration and > 14 TFG points were characterized by higher average values of
CTLA-4
protein in PBMCs. Our data also demonstrated significant differences between Foxp3 protein levels in relation to pT (p = 0.04), depth of invasion (p = = 0.02) and type of invasion (p = 0.03). In tumors with the highest invasiveness identified by the
pT3
-pT4 status, deep invasion with involvement of cartilage and diffuse infiltration, the highest Foxp3 protein level was observed. In conclusion, these results suggest an impact of
CTLA-4
and Foxp3 in determining proliferative and aggressive potential of laryngeal carcinoma, highlighting the significance of
CTLA-4
and Foxp3 as potential predictive indicators.
...
PMID:Expression of CTLA-4 and Foxp3 in peripheral blood T cells of patients with squamous cell laryngeal carcinoma. 2459 25